The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Vascular burden and Alzheimer disease pathologic progression
Open accessAbstract
OBJECTIVE: To investigate the vascular contribution to longitudinal changes in Alzheimer disease (AD) biomarkers. METHODS: The Alzheimer's Disease Neuroimaging Initiative is a clinic based, longitudinal study with CSF, PET, and MRI biomarkers repeatedly measured in participants with normal cognition (NC), mild cognitive impairment (MCI), and mild AD. Participants with severe cerebrovascular risks were excluded. Cardiovascular risk scores and MRI white matter hyperintensities (WMHs) were treated as surrogate markers for vascular burden. Generalized estimating equations were applied, and both vascular burden and its interaction with time (vascular burden × time) or time-varying WMHs were entered into regression models to assess whether biomarker rates of change were modified by vascular burden. RESULTS: Cardiovascular risk profiles were not predictive of progression in CSF β₄₂-amyloid, [¹⁸F]fluorodeoxyglucose (FDG) PET uptake, and MRI hippocampal atrophy. Greater baseline cardiovascular risks or WMHs were generally associated with cognitive impairment, particularly poor executive function. WMHs increased over time with a faster rate in MCI and AD than in NC. Increased time-varying WMH was associated with faster decline in executive function and lower FDG uptake in NC. Otherwise, WMH was not associated with CSF and MRI biomarkers in the 3 groups. These findings remained unchanged after accounting for APOE4. CONCLUSION: Increased WMHs are associated with aging, decreased glucose metabolism, and decline in executive function but do not affect AD-specific pathologic progression, suggesting that the vascular contribution to dementia is probably additive although not necessarily independent of the amyloid pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Modern CSF biomarkers may support a direct relationship between SVD and AD pathology [195], although in the Alzheimer Disease Neuroimaging Initiative that is focused on AD, no interactions were noted between vascular risk factors and AD biomarkers [26].”
From The overlap between vascular disease and Alzheimer’s disease - lessons from pathology (2014) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationModels for Longitudinal Data: A Generalized Estimating Equation Approach
Zeger, S. L., Liang, K., & Albert, P. S. (1988) · Biometrics · doi:10.2307/2531734 · Cited by 4,505
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Self-citationAlzheimer's Disease Neuroimaging Initiative (ADNI)
Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572
Self-citationMixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
Bell, R. D., & Zloković, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 884
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.
Snowdon, D. A., Greiner, L. H., Mortimer, J. A., et al. (1997) · PubMed · Cited by 846
Association of apolipoprotein E genotypes with lipid levels and coronary risk
Bennet, A. M., Di Angelantonio, E., Ye, Z., Wensley, F., Dahlin, A., Ahlbom, A., Keavney, B., Collins, R., Wiman, B., de Faire, U., et al. (2007) · JAMA · doi:10.1001/jama.298.11.1300 · Cited by 794
Cited by
Sorted by citations
Religious Orders Study and Rush Memory and Aging Project
Bennett, D. A., Buchman, A. S., Boyle, P. A., Barnes, L. L., Wilson, R. S., & Schneider, J. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179939 · Cited by 1,260
The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739
“Modern CSF biomarkers may support a direct relationship between SVD and AD pathology [195], although in the Alzheimer Disease Neuroimaging Initiative that is focused on AD, no interactions were noted between vascular risk factors and AD biomarkers [26].”
BackgroundPathology and pathogenesis of vascular cognitive impairment—a critical update
Jellinger, K. A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00017 · Cited by 353
Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.001 · Cited by 348
Self-citationVascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Preboske, G. M., Kantarci, K., Raman, M. R., Machulda, M. M., Mielke, M. M., Lowe, V. J., et al. (2015) · Brain · doi:10.1093/brain/awu393 · Cited by 299
Self-citationThe Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015
Jagust, W. J., Landau, S. M., Koeppe, R. A., Reiman, E. M., Chen, K., Mathis, C. A., Price, J. C., Foster, N. L., & Wang, A. Y. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.05.001 · Cited by 302
Self-citationAging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology
Head, E., T. Lott, I., M. Wilcock, D., & A. Lemere, C. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666151020114607 · Cited by 289
Brickman, A. M., Zahodne, L. B., Guzman, V. A., Narkhede, A., Meier, I. B., Griffith, E. Y., Provenzano, F. A., Schupf, N., Manly, J. J., Stern, Y., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.019 · Cited by 265
Self-citationImpact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J. M., Donohue, M., Green, R. C., Harvey, D. J., Jack, C. R., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.04.005 · Cited by 249
Self-citationMixed pathology is more likely in black than white decedents with Alzheimer dementia
Barnes, L. L., Leurgans, S., Aggarwal, N. T., Shah, R. C., Arvanitakis, Z., James, B. D., Buchman, A. S., Bennett, D. A., & Schneider, J. A. (2015) · Neurology · doi:10.1212/wnl.0000000000001834 · Cited by 236
Self-citationSmailagic, N., Vacante, M., Hyde, C., Martin, S., Ukoumunne, O. C., & Sachpekidis, C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010632.pub2 · Cited by 235
Magnetic resonance imaging in Alzheimer’s disease neuroimaging initiative 2
Jack, C. R., Barnes, J., Bernstein, M. A., Borowski, B. J., Brewer, J., Clegg, S., Dale, A. M., Carmichael, O., Ching, C., DeCarli, C., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.002 · Cited by 220
Self-citationWhite Matter Hyperintensities and Their Penumbra Lie Along a Continuum of Injury in the Aging Brain
Maillard, P., Fletcher, E. M., Lockhart, S. N., Roach, A. E., Reed, B., Mungas, D., DeCarli, C. S., & Carmichael, O. T. (2014) · Stroke · doi:10.1161/strokeaha.113.004084 · Cited by 186
Self-citationJiménez-Baladó, J., & Eich, T. S. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.01.005 · Cited by 194
White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
Araque Caballero, M. Á., Suárez-Calvet, M., Duering, M., Franzmeier, N., Benzinger, T., Fagan, A. M., Bateman, R. J., Jack, C. R., Levin, J., Dichgans, M., et al. (2018) · Brain · doi:10.1093/brain/awy229 · Cited by 184
Self-citationWhite matter hyperintensity topography in Alzheimer's disease and links to cognition
Garnier‐Crussard, A., Bougacha, S., Wirth, M., Dautricourt, S., Sherif, S., Landeau, B., Gonneaud, J., De Flores, R., de la Sayette, V., Vivien, D., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12410 · Cited by 170
Are Empirically-Derived Subtypes of Mild Cognitive Impairment Consistent with Conventional Subtypes?
Clark, L. R., Delano-Wood, L., Libon, D. J., McDonald, C. R., Nation, D. A., Bangen, K. J., Jak, A. J., Au, R., Salmon, D. P., & Bondi, M. W. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617713000313 · Cited by 167
Kester, M. I., Goos, J. D. C., Teunissen, C. E., Benedictus, M. R., Bouwman, F. H., Wattjes, M. P., Barkhof, F., Scheltens, P., & van der Flier, W. M. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.754 · Cited by 161
Clinical and imaging features of mixed Alzheimer and vascular pathologies
Chui, H. C., & Ramirez-Gomez, L. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0104-7 · Cited by 124
Bangen, K. J., Nation, D. A., Delano‐Wood, L., Weissberger, G. H., Hansen, L. A., Galasko, D. R., Salmon, D. P., & Bondi, M. W. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.025 · Cited by 118
The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment
Tosto, G., Zimmerman, M. E., Hamilton, J. L., Carmichael, O. T., Brickman, A. M., & Initiative, A. D. N. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.014 · Cited by 112
Self-citationCerebral Small Vessel Disease and Alzheimer's Disease: A Review
Kim, H. W., Hong, J., & Jeon, J. C. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00927 · Cited by 111
Lee, M. J., Seo, S. W., Na, D. L., Kim, C., Park, J. H., Kim, G. H., Kim, C. H., Noh, Y., Cho, H., Kim, H. J., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4506 · Cited by 105
Self-citationCerebral small vessel disease and the risk of Alzheimer’s disease: A systematic review
Liu, Y., Braidy, N., Poljak, A., Chan, D. K. Y., & Sachdev, P. S. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.06.002 · Cited by 107
Medical Comorbidity in Alzheimer’s Disease: A Nested Case-Control Study
Wang, J., Wu, Y.-J., Tee, B. L., & Lo, R. Y. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170786 · Cited by 107
Self-citationMETACOHORTS Consortium, Dichgans, M., Wardlaw, J., Smith, E., Zietemann, V., Seshadri, S., Sachdev, P., Biessels, G. J., Fazekas, F., Benavente, O., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.004 · Cited by 101
Self-citationArvanitakis, Z., Fleischman, D. A., Arfanakis, K., Leurgans, S. E., Barnes, L. L., & Bennett, D. A. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1034-7 · Cited by 104
Kandel, B. M., Avants, B., Gee, J. C., McMillan, C. T., Erus, G., Doshi, J. J., Davatzikos, C. A., Wolk, D. A., & Initiative, A. D. N. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.03.001 · Cited by 98
Self-citationCharacterization of White Matter Hyperintensities in Large-Scale MRI-Studies
Frey, B. M., Petersen, M., Mayer, C., Schulz, M., Cheng, B., & Thomalla, G. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00238 · Cited by 91
Longitudinal change of small-vessel disease-related brain abnormalities
Schmidt, R., Seiler, S., & Loitfelder, M. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.72 · Cited by 92
Weaker circadian activity rhythms are associated with poorer executive function in older women
Walsh, C. M., Blackwell, T., Tranah, G. J., Stone, K. L., Ancoli-Israel, S., Redline, S., Paudel, M., Kramer, J. H., & Yaffe, K. (2014) · Sleep · doi:10.5665/sleep.4260 · Cited by 88
A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers
Lawrence, E., Vegvari, C., Ower, A. K., Hadjichrysanthou, C., de Wolf, F., & Anderson, R. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170261 · Cited by 89
White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease
Soldan, A., Pettigrew, C. A., Zhu, Y., Wang, M., Moghekar, A., Gottesman, R. F., Singh, B., Martinez, O., Fletcher, E. M., DeCarli, C. S., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008864 · Cited by 82
Self-citationDiabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study
van Arendonk, J., Neitzel, J., Steketee, R. M. E., van Assema, D. M. E., Vrooman, H. A., Segbers, M., Ikram, M. A., & Vernooij, M. W. (2022) · Brain · doi:10.1093/brain/awac354 · Cited by 85
Cerebral white matter hyperintensities in the prediction of cognitive decline and incident dementia
Mortamais, M., Artéro, S., & Ritchie, K. A. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.838151 · Cited by 85
Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer’s disease
Taylor, A. N. W., Kambeitz-Ilankovic, L., Gesierich, B., Simon-Vermot, L., Franzmeier, N., Araque Caballero, M. Á., Müller, S., Hesheng, L., Ertl-Wagner, B., Bürger, K., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.2358 · Cited by 73
Self-citationAdav, S. S., & Sze, S. K. (2016) · Molecular Brain · doi:10.1186/s13041-016-0272-9 · Cited by 75
Cerebral Hypoxia: Its Role in Age-Related Chronic and Acute Cognitive Dysfunction
Snyder, B., Simone, S. M., Giovannetti, T., & Floyd, T. F. (2021) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005525 · Cited by 70
Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories.
Kim, H., Yang, J.-J., Kwon, H., Kim, C., Lee, J., Chun, P., Kim, Y., Jung, N.-Y., Chin, J., Kim, S., et al. (2016) · Brain : a journal of neurology · doi:10.1093/brain/aww148 · Cited by 64
Self-citationBahrani, A. A., Powell, D. K., Yu, G., Johnson, E. S., Jicha, G. A., & Smith, C. D. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2016.10.017 · Cited by 68
Self-citationWhite Matter Hyperintensities as Early and Independent Predictors of Alzheimer's Disease Risk
Mortamais, M., Artéro, S., & Ritchie, K. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141473 · Cited by 69
Bos, I., Vos, S. J. B., Schindler, S. E., Hassenstab, J. J., Xiong, C., Grant, E., Verhey, F. R. J., Morris, J. C., Visser, P. J., & Fagan, A. M. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.04.015 · Cited by 68
Self-citationLorius, N., Locascio, J. J., Rentz, D. M., Johnson, K. A., Sperling, R. A., Viswanathan, A., & Marshall, G. A. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000043 · Cited by 62
Self-citationSudre, C. H., Cardoso, M. J., Frost, C. D., Barnes, J., Barkhof, F., Fox, N. C., & Sebastien Ourselin, A. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.01.014 · Cited by 62
Self-citationBos, I., Verhey, F. R. J., Ramakers, I. H. G. B., Jacobs, H. I. L., Soininen, H. S., Freund‐Levi, Y., Hampel, H. J., Tsolaki, M., Wallin, Å. K., van Buchem, M. A., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0328-9 · Cited by 62
Wang, R., Fratiglioni, L., Kalpouzos, G., Lövdén, M., Laukka, E. J., Bronge, L. H., Wahlund, L., Bäckman, L., & Qiu, C. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.2363 · Cited by 61
Cerebral Amyloid and Hypertension are Independently Associated with White Matter Lesions in Elderly
Scott, J. A., Braskie, M. N., Tosun, D., Thompson, P. M., Weiner, M. W., DeCarli, C. S., & Carmichael, O. T. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00221 · Cited by 62
Self-citationNelson, L., Gard, P., & Tabet, N. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140024 · Cited by 59
Sudduth, T. L., Weekman, E. M., Brothers, H. M., Braun, K. J., & Wilcock, D. M. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt262 · Cited by 56
Smith, C. D., Johnson, E. S., Eldik, L. J. V., Jicha, G. A., Schmitt, F. A., Nelson, P. T., Kryscio, R. J., Murphy, R. R., & Wellnitz, C. V. (2016) · Brain and Behavior · doi:10.1002/brb3.438 · Cited by 54
Self-citationSchreiber, S., Drukarch, B., Garz, C., Niklass, S., Stanaszek, L., Kropf, S., Bueche, C. Z., Held, F., Vielhaber, S., Attems, J., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132618 · Cited by 55
Coutu, J., (ADNI), T. A. D. N. I., Goldblatt, A. E. A., Rosas, H. D., & Salat, D. H. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150306 · Cited by 51
Caballero, M. Á. A., Song, Z., Rubinski, A., Duering, M., Dichgans, M., Park, D. C., & Ewers, M. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12062 · Cited by 52
Disease progression and regression in sporadic small vessel disease–insights from neuroimaging
van Leijsen, E. M. C., de Leeuw, F., & Tuladhar, A. M. (2017) · Clinical Science · doi:10.1042/cs20160384 · Cited by 52
Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline
Pettigrew, C. A., Soldan, A., Wang, J., Wang, M., Arthur, K. C., Moghekar, A., Gottesman, R. F., & Albert, M. (2020) · Neurology · doi:10.1212/wnl.0000000000010946 · Cited by 52
Self-citationReduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI
de Eulate, R. G., Goñi, I., Galiano, A., Vidorreta, M., Recio, M., Riverol, M., Zubieta, J. L., & Fernández-Seara, M. A. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161222 · Cited by 48
The role of cerebrovascular disease when there is concomitant Alzheimer disease
Vemuri, P., & Knopman, D. S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.013 · Cited by 48
Quinlan, P. S., Horváth, A., Wallin, A., & Svensson, J. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.002 · Cited by 46
Longitudinal changes in sulcal morphology associated with late-life aging and MCI
Liu, T., Sachdev, P. S., Lipnicki, D. M., Jiang, J., Cui, Y. J., Kochan, N. A., Reppermund, S., Trollor, J. N., Brodaty, H., & Wen, W. X. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.02.047 · Cited by 45
Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings
Braskie, M. N., & Thompson, P. M. (2013) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2013.08.007 · Cited by 48
Self-citationLi, G., Millard, S. P., Peskind, E. R., Zhang, J., Yu, C., Leverenz, J. B., Mayer, C. L., Shofer, J., Raskind, M. A., Quinn, J. F., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.445 · Cited by 45
Self-citationAmyloid Positivity in the Alzheimer/Subcortical-Vascular Spectrum
Kang, S. H., Kim, M. E., Jang, H., Kwon, H., Lee, H., Kim, H. J., Seo, S. W., & Na, D. L. (2021) · Neurology · doi:10.1212/wnl.0000000000011833 · Cited by 41
Vascular risk burden is a key player in the early progression of Alzheimer’s disease
Ferrari‐Souza, J. P., Brum, W. S., Hauschild, L. A., Ros, L. U. D., Ferreira, P. C. L., Bellaver, B., Leffa, D. T., Bieger, A., Tissot, C., Lussier, F. Z., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.12.008 · Cited by 40
Dodge, H. H., Zhu, J. Y., Woltjer, R. L., Nelson, P. T., Bennett, D. A., Cairns, N. J., Fardo, D. W., Kaye, J. A., Erten‐Lyons, D., Mattek, N., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.11.003 · Cited by 40
Self-citationDrake, J., Initiative, A. D. N., Chambers, A. B., Ott, B. R., & Daiello, L. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200759 · Cited by 41
Self-citationHawkes, C. A., Michalski, D., Anders, R. M., Nissel, S., Grosche, J., Bechmann, I., Carare, R. O., & Härtig, W. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.09.020 · Cited by 39
Kandiah, N., Chander, R. J., Ng, A. Y. T., Wen, M., Cenina, A. R., & Assam, P. N. (2014) · European Journal of Neurology · doi:10.1111/ene.12546 · Cited by 38
Houck, A. L., Gutierrez, J., Gao, F., Igwe, K. C., Colón, J. M., Black, S. E., & Brickman, A. M. (2019) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6213 · Cited by 31
Self-citationPathogenesis and Treatment of Vascular Cognitive Impairment
Jellinger, K. A. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.37 · Cited by 30
Situated Prevention: Framing the “New Dementia”
Leibing, A. (2018) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110518804232 · Cited by 31
Hommet, C., Mondon, K., Camus, V., Ribeiro, M. J., Beaufils, É., Arlicot, N., Corcia, P., Paccalin, M., Minier, F., Gosselin, T., et al. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000354363 · Cited by 36
Ioannou, K., Bucci, M., Tzortzakakis, A., Savitcheva, I., Nordberg, A. K., Chiotis, K., & Initiative, A. D. N. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02672-9 · Cited by 35
Cui, K., Song, R., Xu, H., Shang, Y., Qi, X., Buchman, A. S., Bennett, D. A., & Xu, W. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017346 · Cited by 29
Ge, T., Nichols, T. E., Ghosh, D., Mormino, E. C., Smoller, J. W., & Sabuncu, M. R. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.01.029 · Cited by 31
Stroke risk interacts with Alzheimer's disease biomarkers on brain aging outcomes
Hohman, T. J., Samuels, L. R., Liu, D., Gifford, K. A., Mukherjee, S., Benson, E. M., Abel, T. W., Ruberg, F. L., & Jefferson, A. L. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.021 · Cited by 29
Shi, D., Xie, S., Li, A., Wang, Q., Guo, H., Han, Y., Xu, H., Gan, W., Zhang, L., Guo, T., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01899-w · Cited by 25
Amyloid burden and white matter hyperintensities mediate age-related cognitive differences
Dupont, P. S., Bocti, C., Joannette, M., Lavallée, M. M., Nikelski, J., Vallet, G. T., Chertkow, H., & Joubert, S. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.025 · Cited by 25
Self-citationNutrition and the brain: what advice should we give?
Cooper, J. K. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.029 · Cited by 25
Newton, P., the BIOCARD Research Team, Tchounguen, J., Pettigrew, C., Lim, C., Lin, Z., Lu, H., Moghekar, A., Albert, M., & Soldan, A. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220846 · Cited by 23
Self-citationFerreira, L. K., Tamashiro-Duran, J. H., Squarzoni, P., Duran, F., Alves, T. C. T. F., Buchpiguel, C. A., & Busatto, G. F. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1275 · Cited by 24
Weissberger, G. H., Gollan, T. H., Bondi, M. W., Nation, D. A., Hansen, L. A., Galasko, D. R., & Salmon, D. P. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180351 · Cited by 23
Pillai, J. A., Butler, R. S., Bonner‐Jackson, A., & Leverenz, J. B. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000448243 · Cited by 22
Mixed Brain Pathology Is the Most Common Cause of Cognitive Impairment in the Elderly
Alafuzoff, I. I., & Libard, S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200925 · Cited by 21
An Overview of Experimental and Clinical Spinal Cord Findings in Alzheimer’s Disease
Xie, Q., Zhao, W., Ou, G., & Xue, W. (2019) · Brain Sciences · doi:10.3390/brainsci9070168 · Cited by 20
The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease
Jang, H., Initiative, A. D. N., Kim, H. J., Choe, Y. S., Kim, S.-J., Park, S., Kim, Y., Kim, K. W., Lyoo, C. H., Cho, H., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200680 · Cited by 20
Self-citationTHE EFFECT OF VASCULAR NEUROPATHOLOGY ON LATE-LIFE COGNITION: RESULTS FROM THE SMART PROJECT
Kryscio, R. J., Abner, E. L., Nelson, P. T., Bennett, D. A., Schneider, J., Yu, L., Hemmy, L. S., Lim, K. O., Masaki, K., Cairns, N. J., et al. (2016) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2016.95 · Cited by 19
Self-citationIntravital imaging in spontaneously hypertensive stroke-prone rats-a pilot study
Niklass, S., Stoyanov, S., Garz, C., Bueche, C. Z., Mencl, S., Reymann, K. G., Heinze, H., Carare, R. O., Kleinschnitz, C., & Schreiber, S. (2014) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-6-1 · Cited by 18
Independent value added by diffusion MRI for prediction of cognitive function in older adults
Scott, J. A., Tosun, D., Braskie, M. N., Maillard, P., Thompson, P. M., Weiner, M. W., DeCarli, C. S., & Carmichael, O. T. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.01.026 · Cited by 20
Self-citationLongitudinal Effects of Metabolic Syndrome on Alzheimer and Vascular Related Brain Pathology
Lin, F. V., Lo, R. Y., Cole, D., Ducharme, S., Chen, D., Mapstone, M. E., Porsteinsson, A. P., & Initiative, A. D. N. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000363285 · Cited by 17
Self-citationYu, L., Dawe, R. J., Buchman, A. S., Boyle, P. A., Schneider, J. A., Arfanakis, K., & Bennett, D. A. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.09.001 · Cited by 17
Boreu, Q. F., Guàrdia-Sancho, A., Santos, J. M., Poch, P. R., Ginesta, J. P., Puig-Ribera, A. M., & Muñoz-Padros, J. (2019) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2019.1676709 · Cited by 17
Gold, B. T., Brown, C. A., Hakun, J. G., Shaw, L. M. J., Trojanowski, J. Q., & Smith, C. D. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.012 · Cited by 17
Self-citationEtten, E. J. V., Bharadwaj, P. K., Nguyen, L. A., Hishaw, G. A., Trouard, T. P., & Alexander, G. E. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.012 · Cited by 18
Self-citationDeCarlo, C. A., MacDonald, S. W. S., Vergote, D., Jhamandas, J. H., Westaway, D. A., & Dixon, R. A. (2015) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbv043 · Cited by 16
White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline
Nolze-Charron, G., Mouiha, A., Duchesne, S., Bocti, C., & Initiative, A. D. N. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-140618 · Cited by 16
Amyloid Dysmetabolism Relates to Reduced Glucose Uptake in White Matter Hyperintensities
Kalheim, L. F., Selnes, P., Bjørnerud, A., Coello, C. S., Vegge, K., & Fladby, T. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00209 · Cited by 17
Longitudinal associations of cardiovascular health and vascular events with incident dementia
Ou, Y., Kuo, K., Liu, Y., Zhang, Y.-R., Huang, S., Chen, S.-D., Deng, Y., Guo, Y., Zhang, R., Wu, B., et al. (2023) · Stroke and Vascular Neurology · doi:10.1136/svn-2023-002665 · Cited by 15
Peng, S., Shen, Y., Wang, M., & Zhang, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00193 · Cited by 14
Twait, E. L., Min, B., Beran, M., Vonk, J. M. J., & Geerlings, M. I. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101952 · Cited by 15
An, H., Choi, B., Son, S. J., Cho, E. Y., Kim, S., Cho, S., Kang, D., Lee, C., Kim, S. Y., & Initiative, A. D. N. (2017) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12985 · Cited by 14
Metadata
- Authors
- Lo, R. Y., Jagust, W. J., Weiner, M., Aisen, P., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., Toga, A. W., Beckett, L., Green, R. C., Saykin, A. J., Morris, J., Liu, E., Green, R. C., Montine, T., Petersen, R., Aisen, P., Gamst, A., Thomas, R. G., Donohue, M., Walter, S., Gessert, D., Sather, T., Beckett, L., Harvey, D., Gamst, A., Donohue, M., Kornak, J., Jack, C. R., Dale, A., Bernstein, M., Felmlee, J., Fox, N., Thompson, P., Schuff, N., Alexander, G., DeCarli, C., Jagust, W., Bandy, D., Koeppe, R. A., Foster, N., Reiman, E. M., Chen, K., Mathis, C., Morris, J., Cairns, N. J., Taylor-Reinwald, L., Trojanowki, J. Q., Shaw, L., Lee, V. M. Y., Korecka, M., Toga, A. W., Crawford, K., Neu, S., Saykin, A. J., Foroud, T. M., Potkin, S., Shen, L., Kachaturian, Z., Frank, R., Snyder, P. J., Molchan, S., Kaye, J., Quinn, J., Lind, B., Dolen, S., Schneider, L. S., Pawluczyk, S., Spann, B. M., Brewer, J., Vanderswag, H., Heidebrink, J. L., Lord, J. L., Petersen, R., Johnson, K., Doody, R. S., Villanueva-Meyer, J., Chowdhury, M., Stern, Y., Honig, L. S., Bell, K. L., Morris, J. C., Ances, B., Carroll, M., Leon, S., Mintun, M. A., Schneider, S., Marson, D., Griffith, R., Clark, D., Grossman, H., Mitsis, E., Romirowsky, A., deToledo-Morrell, L., Shah, R. C., Duara, R., Varon, D., Roberts, P., Albert, M., Onyike, C., Kielb, S., Rusinek, H., de Leon, M. J., Glodzik, L., De Santi, S., Doraiswamy, P. M., Petrella, J. R., Coleman, R. E., Arnold, S. E., Karlawish, J. H., Wolk, D., Smith, C. D., Jicha, G., Hardy, P., Lopez, O. L., Oakley, M., Simpson, D. M., Porsteinsson, A. P., Goldstein, B. S., Martin, K., Makino, K. M., Ismail, M. S., Brand, C., Mulnard, R. A., Thai, G., Mc-Adams-Ortiz, C., Womack, K., Mathews, D., Quiceno, M., Diaz-Arrastia, R., King, R., Weiner, M., Martin-Cook, K., DeVous, M., Levey, A. I., Lah, J. J., Cellar, J. S., Burns, J. M., Anderson, H. S., Swerdlow, R. H., Apostolova, L., Lu, P. H., Bartzokis, G., Silverman, D. H. S., Graff-Radford, N. R., Parfitt, F., Johnson, H., Farlow, M. R., Hake, A. M., Matthews, B. R., Herring, S., van Dyck, C. H., Carson, R. E., MacAvoy, M. G., Chertkow, H., Bergman, H., Hosein, C., Black, S., Stefanovic, D. B., Caldwell, C., Hsiung, G.-Y. R., Feldman, H., Mudge, B., Assaly, M., Kertesz, A., Rogers, J., Trost, D., Bernick, C., Munic, D., Kerwin, D., Mesulam, M.-M., Lipowski, K., Wu, C.-K., Johnson, N., Sadowsky, C., Martinez, W., Villena, T., Turner, R. S., Johnson, K., Reynolds, B., Sperling, R. A., Johnson, K. A., Marshall, G., Frey, M., Yesavage, J., Taylor, J. L., Lane, B., Rosen, A., Tinklenberg, J., Sabbagh, M., Belden, C., Jacobson, S., Kowall, N., Killiany, R., Budson, A. E., Norbash, A., Johnson, P. L., Obisesan, T. O., Wolday, S., Bwayo, S. K., Lerner, A., Hudson, L., Ogrocki, P., Fletcher, E., Carmichael, O., Olichney, J., DeCarli, C., Kittur, S., Borrie, M., Lee, T.-Y., Bartha, D. R., Johnson, S., Asthana, S., Carlsson, C. M., Potkin, S. G., Preda, A., Nguyen, D., Tariot, P., Fleisher, A., Reeder, S., Bates, V., Capote, H., Rainka, M., Scharre, D. W., Kataki, M., Zimmerman, E. A., Celmins, D., Brown, A. D., Pearlson, G. D., Blank, K., Anderson, K., Saykin, A. J., Santulli, R. B., Schwartz, E. S., Sink, K. M., Williamson, J. D., Garg, P., Watkins, F., Ott, B. R., Querfurth, H., Tremont, G., Salloway, S., Malloy, P., Correia, S., Rosen, H. J., Miller, B. L., Mintzer, J., Longmire, C. F., Spicer, K., Finger, E., Rachinsky, I., Rogers, J., Kertesz, A., & Drost, D.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- From the Division of Epidemiology, School of Public Health (R.Y.L., W.J.J.), and Helen Wills Neuroscience Institute (W.J.J.), University of California, Berkeley; Department of Neurology (R.Y.L.), Buddhist Tzu Chi General Hospital, Hualien, Taiwan; College of Medicine (R.Y.L.), Tzu Chi University, Hualien, Taiwan; and Life Sciences Division (W.J.J.), Lawrence Berkeley National Laboratory, Berkeley, CA.
- U Pennsylvania
- Janssen Alzheimer Immunotherapy
- University of Washington (US)
- University of California San Diego (US)
- University of California, Davis (US)
- Mayo Clinic, Rochester
- Mayo Clinic (US)
- University of London (GB)
- University of California, Los Angeles (US)
- University of California, San Francisco (US)
- Banner Alzheimer’s Institute (US)
- University of Michigan (US)
- University of Utah (US)
- University of Pittsburgh
- Washington University in St. Louis (US)
- Washington University St. Louis
- UPenn School of Medicine (Core PI)
- University of Pennsylvania (US)
- Indiana University (US)
- UC Irvine
- Buddhist Tzu Chi General Hospital (TW)
- Alzheimer's Association (US)
- General Electric (United States) (US)
- University of Connecticut (US)
- National Institutes of Health (US)
- Oregon Health & Science University (US)
- University of Southern California (US)
- Brigham and Women's Hospital (US)
- Baylor College of Medicine (US)
- Baylor College of Medicine
- Columbia University Irving Medical Center (US)
- Washington University, St. Louis
- University of Alabama at Birmingham (US)
- Icahn School of Medicine at Mount Sinai (US)
- Rush University Medical Center
- Rush University Medical Center (US)
- Wein Center
- Johns Hopkins University (US)
- New York University (US)
- New York University
- Duke Medical Center (US)
- University of Kentucky (US)
- University of Kentucky
- University of Pittsburgh (US)
- University of Rochester Medicine (US)
- University of California, Irvine (US)
- The University of Texas Southwestern Medical Center (US)
- Emory University (US)
- University of Kansas Medical Center (US)
- Mayo Clinic, Jacksonville
- Mayo Clinic in Florida (US)
- Yale University School of Medicine
- Yale University (US)
- Jewish General Hospital (CA)
- Sunnybrook Health Science Centre (CA)
- Sunnybrook Health Sciences, Ontario
- U.B.C. Clinic for AD & Related Disorders
- Cognitive Neurology - St. Joseph's, Ontario
- Cleveland Clinic (US)
- Northwestern University (US)
- Northwestern University
- Palm Beach Neurology (US)
- Premiere Research Inst (Palm Beach Neurology)
- Georgetown University Medical Center (US)
- Stanford University (US)
- Banner Sun Health Research Institute (US)
- Boston University (US)
- Howard University (US)
- Case Western Reserve University (US)
- Neurological Care of CNY
- Parkwood Hospital
- University of Wisconsin System (US)
- University of California, Irvine - BIC
- Dent Neurologic Institute (US)
- The Ohio State University (US)
- Albany Medical College (US)
- Hartford Hospital (US)
- Dartmouth–Hitchcock Medical Center (US)
- Wake Forest University Health Sciences (US)
- Rhode Island Hospital (US)
- Butler Hospital (US)
- Medical University of South Carolina (US)
- St. Joseph's Health Care
- ORCID
- Lo, Raymond Y.
- Liu, Enchi
- Thomas, Ronald G.
- Walter, Sarah
- Harvey, Danielle
- Kornak, John
- Dale, Anders
- Felmlee, Joel
- Fox, Nick
- Thompson, Paul
- Koeppe, Robert A.
- Reiman, Eric M.
- Chen, Kewei
- Lee, Virginia M.Y.
- Korecka, Magdalena
- Crawford, Karen
- Foroud, Tatiana M.
- Shen, Li
- Frank, Richard
- Snyder, Peter J.
- Kaye, Jeffrey
- Schneider, Lon S.
- Heidebrink, Judith L.
- Lord, Joanne L.
- Johnson, Kris
- Stern, Yaakov
- Honig, Lawrence S.
- Bell, Karen L.
- Ances, Beau
- Carroll, Maria
- Marson, Daniel
- Clark, David
- Shah, Raj C.
- Duara, Ranjan
- Albert, Marilyn
- Kielb, Stephanie
- Rusinek, Henry
- Glodzik, Lidia
- Doraiswamy, P. Murali
- Petrella, Jeffrey R.
- Arnold, Steven E.
- Karlawish, Jason H.
- Wolk, David
- Smith, Charles D.
- Hardy, Peter
- Porsteinsson, Anton P.
- Ismail, M. Saleem
- Thai, Gaby
- Womack, Kyle
- Quiceno, Mary
- Diaz-Arrastia, Ramon
- Weiner, Myron
- DeVous, Michael
- Levey, Allan I.
- Lah, James J.
- Burns, Jeffrey M.
- Swerdlow, Russell H.
- Apostolova, Liana
- Lu, Po H.
- Silverman, Daniel H.S.
- Johnson, Heather
- Farlow, Martin R.
- Hake, Ann Marie
- Carson, Richard E.
- Chertkow, Howard
- Bergman, Howard
- Hsiung, Ging-Yuek Robin
- Feldman, Howard
- Bernick, Charles
- Kerwin, Diana
- Johnson, Nancy
- Turner, Raymond Scott
- Sperling, Reisa A.
- Johnson, Keith A.
- Marshall, Gad
- Frey, Meghan
- Yesavage, Jerome
- Taylor, Joy L.
- Lane, Barton
- Rosen, Allyson
- Sabbagh, Marwan
- Belden, Christine
- Jacobson, Sandra
- Kowall, Neil
- Killiany, Ronald
- Budson, Andrew E.
- Norbash, Alexander
- Obisesan, Thomas O.
- Lerner, Alan
- Carmichael, Owen
- Olichney, John
- Johnson, Sterling
- Asthana, Sanjay
- Carlsson, Cynthia M.
- Preda, Adrian
- Nguyen, Dana
- Tariot, Pierre
- Fleisher, Adam
- Scharre, Douglas W.
- Kataki, Maria
- Pearlson, Godfrey D.
- Santulli, Robert B.
- Sink, Kaycee M.
- Williamson, Jeff D.
- Garg, Pradeep
- Ott, Brian R.
- Tremont, Geoffrey
- Salloway, Stephen
- Correia, Stephen
- Rosen, Howard J.
- Miller, Bruce L.
- Mintzer, Jacobo
- Venue
- Neurology
- Published
- 2012-09-25
- Volume
- 79
- Issue
- 13
- Pages
- 1349-1355
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC3448744
- OpenAlex
- W2055568131
- Cited by
- 156
- References
- 36
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 4 · 2021: 12 · 2020: 9 · 2019: 10 · 2018: 9 · 2017: 11 · 2016: 18 · 2015: 25 · 2014: 24 · 2013: 13
- FWCI
- 14.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Columbia Academic Commons (Columbia University)
- Funders
- National Institutes of Health (5u01ag024904-10)
- Canadian Institutes of Health Research
- National Institute on Aging (U01-AG-024904, P30AG010129, K01AG030514, P30AG013846, U19AG010483)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- Alzheimer's disease, vascular burden, white matter hyperintensities, cardiovascular risk, mild cognitive impairment, CSF amyloid-beta 42, hippocampal atrophy, executive function decline, APOE ε4, disease progression
- MeSH terms
- Aged, Alzheimer Disease, Atrophy, Brain, Female, Genotype, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Disease Progression, Positron-Emission Tomography, Leukoencephalopathies, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review